ArticleBioinformatics (Oxford, England)2026
PLM-eXplain: divide and conquer the protein embedding space.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.Communications biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationProtein language models (PLMs) have revolutionized computational biology through their ability to generate powerful sequence representations for diverse prediction tasks. However, their black-box nature limits biological interpretation and translation to actionable insights. Bridging this gap requires approaches that maintain predictive performance while providing interpretable explanations of model behaviour.
resultsWe present PLM-eXplain (PLM-X), an explainable adapter layer that bridges this gap by factoring PLM embeddings into two complementary components: an interpretable subspace based on established biochemical features, and a residual subspace that retains predictive, non-interpretable information. Using embeddings from ESM2 and ProtBert, PLM-X incorporates well-established properties, including secondary structure and hydropathy, while maintaining high predictive performance. We demonstrate the effectiveness of our approach across three biologically relevant classification tasks: extracellular vesicle association, transmembrane helix prediction, and aggregation propensity prediction. PLM-X enables biological interpretation of model decisions without sacrificing accuracy, offering a generalizable solution for enhancing PLM interpretability across various downstream applications. AVAILABILITY AND IMPLEMENTATION: Source code and models are available at https://github.com/AIT4LIFE-UU/PLM-eXplain/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.